In conclusion, we have reported a novel and more aggressive insulin-induced insulin resistance protocol applied to mouse 3T3-L1 and human SGBS, characterizing their specific cellular, molecular and functional responses which need to be considered when choosing the cell model to use, and highlighting similarities and discrepancies with other previously published protocols. This evidence concerns the gene INS and Insulin resistance.